US FTC to sue drug middlemen over insulin prices, source says, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

​On Tuesday, the FTC issued an interim report, saying the three biggest middlemen – managing 79% of U.S. prescription drug claims – have used years of dealmaking to gain outsized influence on drug prices. The report said the companies enriched themselves at the expense of smaller pharmacies and consumers., ​On Tuesday, the FTC issued an interim report, saying the three biggest middlemen – managing 79% of U.S. prescription drug claims – have used years of dealmaking to gain outsized influence on drug prices. The report said the companies enriched themselves at the expense of smaller pharmacies and consumers., , Read More